Earnings History for Pernix Therapeutics (PTX)
|
Expand Research on PTX
| Next EPS Date | 6/12/13 *Est. | EPS Growth Rate | -133.3% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | -104.0% | Revenue Growth Rate | -15.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -11.0% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/18/13 | Q412 | -$0.05 | $0.02 | -$0.07 | $18.2M | $22.44M | N/A / N/A | N/A | -42.8% | Details | |
11/14/12  |
 |
Q312 | -$0.01 | $0.03 | -$0.04 | $18.1M | $15.04M | N/A / N/A | N/A | -52.3% | Details |
| 3/28/12 |
|
Q411 | $0.15 | $0.14 | +$0.01 | $21.4M | $20.06M | N/A / N/A | N/A | -62.9% | Details |
| 11/15/11 |
|
Q311 | $0.08 | $0.05 | +$0.03 | $17.1M | $11.81M | N/A / N/A | N/A | -61.4% | Details |
| 8/16/11 | Q211 | $0.07 | $0.03 | +$0.04 | $12M | $7.11M | N/A / N/A | N/A | -45.5% | Details | |
| 5/17/11 |
|
Q111 | $0.04 | $0.14 | -$0.10 | $10.1M | $8.9M | N/A / N/A | N/A | -70.3% | Details |
| 3/31/11 |
|
Q410 | $0.07 | $0.14 | -$0.07 | $12.2M | $13.08M | N/A / N/A | N/A | -68.9% | Details |
| 11/12/10 |
Q310 | $0.10 | N/A | N/A | N/A | N/A | N/A / N/A | N/A | -4.8% | Details |
